Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells

被引:35
|
作者
Pisolato, R. [1 ]
Lombardi, A. P. G. [1 ]
Vicente, C. M. [1 ]
Lucas, T. F. G. [1 ]
Lazari, M. F. M. [1 ]
Porto, C. S. [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Pharmacol, Sect Expt Endocrinol, Escola Paulista Med, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Estrogen receptors alpha and beta; ER-alpha; 36; GPER; ERK1/2; PC-3; cells; RAT SERTOLI-CELLS; ER-ALPHA; ANDROGEN RECEPTOR; DIFFERENTIAL EXPRESSION; VARIANT ER-ALPHA-36; DOWN-REGULATION; BREAST-CANCER; G-PROTEIN; BETA; PROLIFERATION;
D O I
10.1016/j.steroids.2015.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to identify the expression, cellular localization and regulation of classic estrogen receptors ER alpha, and ER beta, ER-alpha 36 isoform and GPER in the androgen-independent prostate cancer cell line PC-3. In addition, we evaluated the relative contribution of these receptors to the activation of the ERK1/2 (extracellular signal-regulated protein kinases) signaling pathway. These four estrogen receptors were detected by Western blot assays and were shown by immunofluorescence assays to localize preferentially in extranuclear regions of PC-3 cells. In addition, treatment with 17 beta-estradiol (E2) (1 mu M) for 24 h led to down-regulation of the classic estrogen receptors, whereas E2 at physiological concentration (0.1 nM) for 24 h tended to increase the levels of ER alpha and ER beta. Furthermore, the ER alpha-selective agonist PPT selectively increased the expression of ER beta and the ER beta-selective agonist DPN increased ER alpha levels. None of these treatments affected expression of the ER-alpha 36 isoform. The unusual cytoplasmic localization of the classic estrogen receptors in these cells differs from the nuclear localization in the majority of estrogen target cells and suggests that rapid signaling pathways may be preferentially activated. In fact, treatment with selective agonists of ER alpha, ER beta and GPER induced ERK1/2 phosphorylation that was blocked by the respective antagonists. On the other hand, activation of ERK1/2 induced by E2 may involve additional mechanisms because it was not blocked by the three antagonists. Taken together, the results indicate that there is a crosstalk between ER alpha and ER beta to regulate the expression of each other, and suggest the involvement of other receptors, such as ER-alpha 36, inthe rapid ERK1/2 activation by E2. The identification of new isoforms of-ERs, regulation of the receptors and signaling pathways is important to develop new therapeutic strategies for the castration-resistant prostate cancer. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:74 / 86
页数:13
相关论文
共 50 条
  • [1] The Glutamatergic System Expression in Human PC-3 and LNCaP Prostate Cancer Cells
    Pissimissis, Nikolaos
    Papageorgiou, Efstathia
    Lembessis, Peter
    Armakolas, Athanasios
    Koutsilieris, Michael
    [J]. ANTICANCER RESEARCH, 2009, 29 (01) : 371 - 377
  • [2] Transport of methotrexate into PC-3 human prostate cancer cells
    Horne, DW
    Reed, KA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 394 (01) : 39 - 44
  • [3] Lysophosphatidic acid upregulates calreticulin expression in PC-3 human prostate cancer cells
    Lu, Kuan-Ying
    Lin, Kuan-Hung
    Lin, Chu Cheng
    Lin, Yueh-Chien
    Yang, Ya-Jan
    Chen, Wei-min
    Hsia, Hsin-Yi
    Lee, Hsinyu
    [J]. FASEB JOURNAL, 2015, 29
  • [4] Effects of dihydroartemisinin on HSP70 expression in human prostate cancer PC-3 cells
    Kong, Jin
    Li, Shan-Shan
    Ma, Qi
    Liu, Lei
    Zheng, Lin-Jing
    [J]. ANDROLOGIA, 2019, 51 (06)
  • [5] Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells
    Hughes-Fulford, M
    Chen, YF
    Tjandrawinata, RR
    [J]. CARCINOGENESIS, 2001, 22 (05) : 701 - 707
  • [6] Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells
    De Ganck, Ariane
    De Corte, Veerle
    Bruyneel, Erik
    Bracke, Marc
    Vandekerckhove, Joel
    Gettemans, Jan
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (05) : 1403 - 1409
  • [7] Eicosanoids regulation of transcription factors in PC-3 prostate cancer cells.
    Kandouz, M
    Honn, KV
    [J]. EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY, 5, 2002, 507 : 563 - 568
  • [8] Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells
    LIU Ranlu ZHANG Zhihong ZHAO Weiming WANG Meng QI Shiyong LI Jing ZHANG Yue LI Shengzhi XU Yong Department of UrologySecond Hospital of Tianjin Medical UniversityTianjin Institute of UrologyTianjin China Tianjin Instimte of UrologyTianjin China
    [J]. 中华医学杂志(英文版), 2008, (04) : 299 - 304
  • [9] Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells
    Liu Ran-Lu
    Zhang Zhi-Hong
    Zhao Wei-Ming
    Wang Meng
    Qi Shi-Yong
    Li Jing
    Zhang Yue
    Li Sheng-Zhi
    Xu Yong
    [J]. CHINESE MEDICAL JOURNAL, 2008, 121 (04) : 299 - 304
  • [10] Polyphenon E Effects on Gene Expression in PC-3 Prostate Cancer Cells
    Carastro, L. Michael
    Vallebuona, Ethan J.
    Cordova, Ricardo
    Gannon, Ashely N.
    Kim, Seung Joon
    Costello, Corrine M.
    Declet-Bauzo, Ricardo A.
    Kumar, Nagi
    Park, Jong Y.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)